Company Overview of SynGlyco, Inc.
SynGlyco, Inc. develops novel vaccines using synthetic carbohydrates. It offers immune system modulation therapeutics. SynGlyco, Inc. was formerly known as Ancora Pharmaceuticals, Inc. and changed its name to SynGlyco, Inc. in November 2013. The company was incorporated in 2001 and is based in Woburn, Massachusetts.
1 Gill Street
Woburn, MA 01801
Founded in 2001
Key Executives for SynGlyco, Inc.
Similar Private Companies By Industry
|21st Century Animal Health||United States|
|3 Buds' Organics LLC||United States|
|4P Therapeutics LLC||United States|
|60° Pharmaceuticals, LLC||United States|
|7 Oaks Pharmaceutical Corp.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|Bloomberg L.P.||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
Sponsored Financial Commentaries
To contact SynGlyco, Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.